These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24480192)

  • 1. Identifying factors hampering physical activity in longstanding rheumatoid arthritis: what is the role of glucocorticoid therapy?
    van der Goes MC; Hoes JN; Cramer MJ; van der Veen MJ; van der Werf JH; Bijlsma JW; Jacobs JW
    Clin Exp Rheumatol; 2014; 32(2):155-61. PubMed ID: 24480192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission.
    Molenaar ET; Voskuyl AE; Dijkmans BA
    J Rheumatol; 2002 Feb; 29(2):267-70. PubMed ID: 11842821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalisation of physical function by infliximab in patients with RA: factors associated with normal physical function.
    Nagasawa H; Kameda H; Sekiguchi N; Amano K; Takeuchi T
    Clin Exp Rheumatol; 2010; 28(3):365-72. PubMed ID: 20525444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D; Smolen JS
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
    Kotak S; Mardekian J; Horowicz-Mehler N; Shah A; Burgess A; Kim J; Gemmen E; Boyd H; Koenig A
    Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept.
    Tanaka Y; Yamanaka H; Saito K; Iwata S; Miyagawa I; Seto Y; Momohara S; Nagasawa H; Kameda H; Kaneko Y; Izumi K; Amano K; Takeuchi T
    Mod Rheumatol; 2012 Apr; 22(2):186-94. PubMed ID: 21901357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage.
    Ahlmén M; Svensson B; Albertsson K; Forslind K; Hafström I;
    Ann Rheum Dis; 2010 Jan; 69(1):230-3. PubMed ID: 19158113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.
    Wassenberg S; Rau R; Steinfeld P; Zeidler H
    Arthritis Rheum; 2005 Nov; 52(11):3371-80. PubMed ID: 16255011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
    Lillegraven S; Prince FH; Shadick NA; Bykerk VP; Lu B; Frits ML; Iannaccone CK; Kvien TK; Haavardsholm EA; Weinblatt ME; Solomon DH
    Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.
    Breedveld FC; Han C; Bala M; van der Heijde D; Baker D; Kavanaugh AF; Maini RN; Lipsky PE
    Ann Rheum Dis; 2005 Jan; 64(1):52-5. PubMed ID: 15286005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported flares are predictors of radiographic progression in rheumatoid arthritis patients in 28-joint disease activity score remission: a 24-month observational study.
    Ometto F; Raffeiner B; Bernardi L; Bostsios C; Veronese N; Punzi L; Doria A
    Arthritis Res Ther; 2016 Apr; 18():89. PubMed ID: 27080123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'.
    Koevoets R; Dirven L; Klarenbeek NB; van Krugten MV; Ronday HK; van der Heijde DM; Huizinga TW; Kerstens PS; Lems WF; Allaart CF
    Ann Rheum Dis; 2013 Jun; 72(6):870-4. PubMed ID: 22753403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
    Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K;
    Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.